The FDA announced that it fully approved the use of remdesivir as a treatment for COVID-19 requiring hospitalization in all adult and some pediatric patients.
Remdesivir is only to be administered in a hospital or healthcare setting capable of providing acute care comparable to inpatient hospital care. The drug, also referred to by the FDA as Veklury, is the first treatment for COVID-19 to receive FDA approval, according to an FDA news release. It can be used for adult patients and pediatric patiens who are over 12 years old and weigh more than 40 kg (88 lb).
Get the full story at our sister site, Drug Discovery & Development.